149 related articles for article (PubMed ID: 36637739)
1. Reproducibility of CT radiomic features in lung neuroendocrine tumours (NETs) patients: analysis in a heterogeneous population.
Bicci E; Cozzi D; Cavigli E; Ruzga R; Bertelli E; Danti G; Bettarini S; Tortoli P; Mazzoni LN; Busoni S; Miele V
Radiol Med; 2023 Feb; 128(2):203-211. PubMed ID: 36637739
[TBL] [Abstract][Full Text] [Related]
2. Radiomics in pulmonary neuroendocrine tumours (NETs).
Cozzi D; Bicci E; Cavigli E; Danti G; Bettarini S; Tortoli P; Mazzoni LN; Busoni S; Pradella S; Miele V
Radiol Med; 2022 Jun; 127(6):609-615. PubMed ID: 35538389
[TBL] [Abstract][Full Text] [Related]
3. Correlation between radiomic features based on contrast-enhanced computed tomography images and Ki-67 proliferation index in lung cancer: A preliminary study.
Zhou B; Xu J; Tian Y; Yuan S; Li X
Thorac Cancer; 2018 Oct; 9(10):1235-1240. PubMed ID: 30070037
[TBL] [Abstract][Full Text] [Related]
4. Can we differentiate histologic subtypes of neuroendocrine tumour liver metastases at a single phase contrast-enhanced CT-correlation with Ga-68 DOTATATE PET/CT findings.
Gulpinar B; Peker E; Soydal C; Araz M; Elhan AH
Br J Radiol; 2020 Feb; 93(1106):20190735. PubMed ID: 31922897
[TBL] [Abstract][Full Text] [Related]
5. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
[TBL] [Abstract][Full Text] [Related]
6. Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
Rufini V; Lorusso M; Inzani F; Pasciuto T; Triumbari EKA; Grillo LR; Locco F; Margaritora S; Pescarmona E; Rindi G
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4182-4193. PubMed ID: 35674739
[TBL] [Abstract][Full Text] [Related]
7. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic imaging of typical lung carcinoids: relationship between MDCT,
Danti G; Berti V; Abenavoli E; Briganti V; Linguanti F; Mungai F; Pradella S; Miele V
Radiol Med; 2020 Aug; 125(8):715-729. PubMed ID: 32189174
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
[TBL] [Abstract][Full Text] [Related]
10. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
11. Deep Learning-based Image Conversion of CT Reconstruction Kernels Improves Radiomics Reproducibility for Pulmonary Nodules or Masses.
Choe J; Lee SM; Do KH; Lee G; Lee JG; Lee SM; Seo JB
Radiology; 2019 Aug; 292(2):365-373. PubMed ID: 31210613
[TBL] [Abstract][Full Text] [Related]
12. Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Hirashima H; Matsuo Y; Mizowaki T
Phys Med; 2020 Jan; 69():176-182. PubMed ID: 31918370
[TBL] [Abstract][Full Text] [Related]
13. Impact of slice thickness on reproducibility of CT radiomic features of lung tumors.
Gupta S; Nayak K; Pendem S
F1000Res; 2023; 12():1319. PubMed ID: 38454921
[TBL] [Abstract][Full Text] [Related]
14. Three dimensional computed tomography texture analysis of pulmonary lesions: Does radiomics allow differentiation between carcinoma, neuroendocrine tumor and organizing pneumonia?
Adelsmayr G; Janisch M; Müller H; Holzinger A; Talakic E; Janek E; Streit S; Fuchsjäger M; Schöllnast H
Eur J Radiol; 2023 Aug; 165():110931. PubMed ID: 37399666
[TBL] [Abstract][Full Text] [Related]
15. Predicting Ki-67 labeling index level in early-stage lung adenocarcinomas manifesting as ground-glass opacity nodules using intra-nodular and peri-nodular radiomic features.
Zhu M; Yang Z; Zhao W; Wang M; Shi W; Cheng Z; Ye C; Zhu Q; Liu L; Liang Z; Chen L
Cancer Med; 2022 Nov; 11(21):3982-3992. PubMed ID: 35332684
[TBL] [Abstract][Full Text] [Related]
16. [Development of a radiomics signature to predict Ki-67 expression level in non-small cell lung cancer].
Gu Q; Feng Z; Liang Q; Li M; Wang W; Rong P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1216-1222. PubMed ID: 30643066
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
18. Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma.
Ahmed AA; Elmohr MM; Fuentes D; Habra MA; Fisher SB; Perrier ND; Zhang M; Elsayes KM
Clin Radiol; 2020 Jun; 75(6):479.e17-479.e22. PubMed ID: 32089260
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
[TBL] [Abstract][Full Text] [Related]
20. CT-based radiomics for prediction of therapeutic response to Everolimus in metastatic neuroendocrine tumors.
Caruso D; Polici M; Rinzivillo M; Zerunian M; Nacci I; Marasco M; Magi L; Tarallo M; Gargiulo S; Iannicelli E; Annibale B; Laghi A; Panzuto F
Radiol Med; 2022 Jul; 127(7):691-701. PubMed ID: 35717429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]